AGRX

Agile Therapeutics, Inc
AGRX

Overview Fund Activity
Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

16 hedge funds and large institutions have $426K invested in Agile Therapeutics, Inc in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 12 closing their positions.

Holders
16
Holders Change
-6
Holders Change %
-27.27%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
2
Reduced
8
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$360K
2
State Street
2
State Street
Massachusetts
$32K
3
TRCT
3
Tower Research Capital (TRC)
New York
$8K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$2K
5
UBS Group
5
UBS Group
Switzerland
$71

Top Sellers

1
LPL Financial
1
LPL Financial
California
$0
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$0
3
VF
3
Virtu Financial
New York
$0
4
ASN
4
Advisory Services Network
Georgia
$0
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CWS
26
Confluence Wealth Services
Pennsylvania
– -$2.52K -225 Closed
Two Sigma Investments
27
Two Sigma Investments
New York
– -$2.26K -201 Closed
1
2